Publications by authors named "B J Thevenin"
Article Synopsis
- Endovascular interventions using Luminor, a nanotechnology-based drug-coated balloon (DCB), have shown effectiveness in treating femoropopliteal lesions, with a large-scale study called the LUMIFOLLOW registry evaluating its real-world performance after it succeeded in prior trials like Effpac.
- The LUMIFOLLOW study involved 542 patients with various comorbidities and lesion types, focusing on safety and efficacy, with primary endpoints including freedom from major complications and target lesion revascularization.
- Results indicated a high procedural success rate of 99.4%, although some patients required stenting and there were minor adverse events, suggesting the treatment is generally effective but may need further assessment in complicated
There is no recovery without a transformation. This is conveyed by a greater ability to adapt to the demands of daily life and a significant reduction in the behavioural expression of symptoms. This is combined with a positive experience of oneself in the present and a firm belief in the continuity of oneself in the future, over the medium term.
View Article and Find Full Text PDFBackground: The aim of this study was to determine the predictive factors of reduction in diameter ≥10 mm of the aneurysm sac after endovascular treatment and analyze evolution in these patients.
Methods: Between December 1997 and December 2008, all patients electively treated at our center for an infrarenal abdominal aortic aneurysm (AAA) were included in a prospective registry. We did a retrospective study between patients whose aneurysm was reduced by at least 10 mm in diameter on computed tomography scan during follow-up (Group 1) and the other patients who did not (Group 2).
Objectives: This study sought to analyze whether the plasmatic level of leukocyte-derived microparticles (LMP) is associated with unstable plaques in patients with high-grade carotid stenosis.
Background: Preventive carotid surgery in asymptomatic patients is currently debated given the improvement of medical therapy. Therefore, noninvasive biomarkers that can predict plaque instability are needed.
Objective: To test plasma levels of lipoprotein-associated phospholipase A2 (Lp-PLA2) in patients with high-grade carotid stenosis according to plaque histology.
Methods: This cross-sectional single-centre study included patients with ≥70% North American Symptomatic Carotid Endarterectomy Trial (NASCET) carotid stenosis, who were treated surgically. Serum Lp-PLA2 and high-sensitivity C-reactive protein (hs-CRP) were determined on the day of surgery.